Skip to main content

Table 3 Comparison of mean (standard deviation) Ct of reference genes analyzed by RT-qPCR, for the 4 centres

From: Importance of pre-analytical steps for transcriptome and RT-qPCR analyses in the context of the phase II randomised multicentre trial REMAGUS02 of neoadjuvant chemotherapy in breast cancer patients

Reference Gene

Centre

All centres

 

1

2

3

4

 

TFR

23.85 (0.87)

24.09 (1.28)

24.23 (1.01)

26.30 (1.82)

24.34 (1.47)

β-actin

17.15 (0.58)

17.34 (1.19)

17.10 (0.62)

18.32 (0.88)

17.38 (0.94)

TBP

26.46 (0.53)

26.53 (1.18)

26.81 (0.47)

28.11 (1.10)

26.77 (1.03)

GAPDH

19.78 (0.94)

19.99 (1.27)

19.90 (0.77)

20.47 (1.05)

19.96 (1.07)

RPLPO

19.44 (0.60)

19.43 (1.06)

19.25 (0.78)

20.51 (0.93)

19.59 (0.91)

GUS

22.84 (0.71)

22.98 (1.23)

23.05 (0.76)

24.83 (1.33)

23.21 (1.21)

p-value referring to ANOVA test for each reference gene, when excluding corresponding centre

TFR

< 0.001

< 0.001

< 0.001

0.144

< 0.001

β-actin

< 0.001

< 0.001

< 0.001

0.256

< 0.001

TBP

< 0.001

< 0.001

< 0.001

0.165

< 0.001

GAPDH

0.075

< 0.001

0.003

0.416

0.006

RPLPO

< 0.001

< 0.001

< 0.001

0.562

< 0.001

GUS

< 0.001

< 0.001

< 0.001

0.457

< 0.001